Impact of corticosteroid therapy on the survival of critical COVID-19 patients admitted into an intensive care unit.

González-Castro, A; Cuenca Fito, E; Fernández, A; Escudero Acha, P; Rodríguez Borregán, J C; Peñasco, Y

González-Castro, A; Cuenca Fito, E; Fernández, A; Escudero Acha, P; Rodríguez Borregán, J C; Peñasco, Y.

González-Castro A; Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain. Electronic address: jandro120475@hotmail.com.
Cuenca Fito E; Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Fernández A; Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Escudero Acha P; Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Rodríguez Borregán JC; Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Peñasco Y; Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Rev Esp Anestesiol Reanim (Engl Ed) ; 69(2): 120-121, 2022 02.

Article in English | MEDLINE | ID: covidwho-1740142

Subject(s)

COVID-19; Adrenal Cortex Hormones/therapeutic use; Hospitalization; Humans; Intensive Care Units

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Rev Esp Anestesiol Reanim (Engl Ed) Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google